octyl salicylate
Small moleculeexperimental
Octisalate used as an ingredient in sunscreens and cosmetics. Maximum FDA-approved concentration - 5%. Range of protection - UVB. Might develop contact allergic dermatitis — NCATS
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jul 1, 2008 (NCT00530387)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetUltraviolet filter
ultraviolet filter
Chemistry & pharmacology
Loading structure…
SMILES
CCCCC(CC)COC(=O)C1=CC=CC=C1O- Mol. weight
- 250.3334 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaOctyl salicylate ↗
- NCATS4X49Y0596W ↗
- ChEMBLCHEMBL1329203 ↗
Also known as
- 2-ethylhexyl salicylate
- ethyl hexyl salicylate
- octisalate
- octisalate
- octisalate
- octisalate
- octisalate
- octisalate
- octisalate
- octisalate
- octylsalicylate
- octyl salicylate
- octyl salicylate
- octyl salicylate
- salicylic acid 2-ethylhexyl ester
- trans-2-hexenyl salicylate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03012347 | N/A | Jan 1, 2017 | Bayer |
| NCT02492945 | Phase 4 | Jun 1, 2015 | Seoul National University |
| NCT00530387 | N/A | Jul 1, 2008 | University of Dundee |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 1 | 1 | 1 | 2017 |
| Seoul National University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Dundee | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1